Cardiopet

DB18913InvestigationalSmall molecule

Cardiopet is under investigation in clinical trial NCT01826773 (Cardiopet as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects).

Chemical structure of Cardiopet
Formula / weight
C18H33FO2 · 299.461 g/mol (avg)
Also known as
(18f fcpha) · (18f)-fcpha · 2-((1s,2r)-2-(5-(fluoro-18f)tridecyl)cyclopropyl)acetic acid · Cyclopropaneacetic acid, 2-(5-(fluoro-18f)tridecyl)-, (1r,2s)-rel- · Trans-9(rs)-18f-fluoro-3,4(rs,rs)-methyleneheptadecanoic acid

Resolves to

Structure
InChIKeyDDTRZLZETKPBPQ-YWWFHXEUSA-NSMILESCCCCCCCCC([18F])CCCC[C@@H]1C[C@H]1CC(O)=O

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Cardiopet, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account